Global Botulinum Toxin Market: Size, Trends and Forecasts (2019-2023 Edition)
The report titled “Global Botulinum Toxin Market: Size, Trends and Forecasts (2019-2023 Edition)” provides an in-depth analysis of the global botulinum toxin market with detailed analysis of the actual and the expected market size along with the market size of each market segment on the basis of application, products as well as regional.
The report provides detailed regional analysis of the US, Europe, Japan, Asia (excluding Japan),Korea and China for the botulinum toxin market. Regional analysis includes market share of each region or country and the actual and forecasted market size of the botulinum toxin market along with the market segments of the aforementioned regions.
The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global botulinum toxin market has also been forecasted for the period 2019-2023, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.
The competition in the global botulinum toxin market is stiff and dominated by the big players like Allergan. Further, key players of the botulinum toxin market Ipsen and Revance are also profiled with their financial information and respective business strategies.
Company Coverage
1. Allergan
2. Ipsen
3. Revance
Regional Coverage
1. The US
2. Europe
3. Japan
4. Asia (excluding Japan)
5. Korea
6. China
EXECUTIVE SUMMARY
Botulinum toxin is provided by a kind of bacteria called as clostridium botulinum, a gram-positive anaerobic bacterium. Botulinum toxin is fragmented into seven separate neurotoxins and used in therapeutic and aesthetic procedures. It is utilized as a part of relatively every sub-forte of pharmaceutical and for restorative reason for briefly lessening glabellar temple glare lines. The different botulinum toxins have singular potencies, and care is required to guarantee appropriate apply and avoid medication errors.
The global botulinum toxin market has increased at a significant annual growth rate in 2018 as compared to the preceding year 2017 and projections are made that the market would rise in the next five years i.e. 2019-2023 tremendously.
On the basis of product, type the market is divided into Botox, Xeomin and Dysport. The market can be segmented on the basis of application as therapeutics and cosmetic/aesthetic, of which therapeutics govern the market.
The major growth drivers for the botulinum toxin market are: ageing population, escalating numbers of surgeons, upsurge in facial aesthetics procedures, rising alternative of non-surgical procedures, increasing healthcare spending in emerging markets. Despite the market is governed by various growth drivers, there are certain challenges faced by the market such as potential health risk associated with botulinum toxin and botulinum toxins as bio-terror threat.
FDA approval to Botulinum Toxin for new indications, rise in medical tourism, reduced safety concerns and simple and instant characteristic and scope of botulinum toxin in treatment of Necrotizing Fasciitis are some of the latest trends existing in the market.
The report provides detailed regional analysis of the US, Europe, Japan, Asia (excluding Japan),Korea and China for the botulinum toxin market. Regional analysis includes market share of each region or country and the actual and forecasted market size of the botulinum toxin market along with the market segments of the aforementioned regions.
The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global botulinum toxin market has also been forecasted for the period 2019-2023, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.
The competition in the global botulinum toxin market is stiff and dominated by the big players like Allergan. Further, key players of the botulinum toxin market Ipsen and Revance are also profiled with their financial information and respective business strategies.
Company Coverage
1. Allergan
2. Ipsen
3. Revance
Regional Coverage
1. The US
2. Europe
3. Japan
4. Asia (excluding Japan)
5. Korea
6. China
EXECUTIVE SUMMARY
Botulinum toxin is provided by a kind of bacteria called as clostridium botulinum, a gram-positive anaerobic bacterium. Botulinum toxin is fragmented into seven separate neurotoxins and used in therapeutic and aesthetic procedures. It is utilized as a part of relatively every sub-forte of pharmaceutical and for restorative reason for briefly lessening glabellar temple glare lines. The different botulinum toxins have singular potencies, and care is required to guarantee appropriate apply and avoid medication errors.
The global botulinum toxin market has increased at a significant annual growth rate in 2018 as compared to the preceding year 2017 and projections are made that the market would rise in the next five years i.e. 2019-2023 tremendously.
On the basis of product, type the market is divided into Botox, Xeomin and Dysport. The market can be segmented on the basis of application as therapeutics and cosmetic/aesthetic, of which therapeutics govern the market.
The major growth drivers for the botulinum toxin market are: ageing population, escalating numbers of surgeons, upsurge in facial aesthetics procedures, rising alternative of non-surgical procedures, increasing healthcare spending in emerging markets. Despite the market is governed by various growth drivers, there are certain challenges faced by the market such as potential health risk associated with botulinum toxin and botulinum toxins as bio-terror threat.
FDA approval to Botulinum Toxin for new indications, rise in medical tourism, reduced safety concerns and simple and instant characteristic and scope of botulinum toxin in treatment of Necrotizing Fasciitis are some of the latest trends existing in the market.
1. EXECUTIVE SUMMARY
2. INTRODUCTION
2.1 Botulinum Toxin: An Overview
2.2 Botulinum Toxin: Indications Overview
2.3 Botulinum Toxin: Products Overview
3. GLOBAL MARKET ANALYSIS
3.1 Global Botulinum Toxin Market: An Analysis
3.1.1 Global Botulinum Toxin Market by Value
3.2 Global Botulinum Toxin Market: Application Analysis
3.2.1 Global Botulinum Toxin Market by Application
3.2.2 Global Therapeutic Botulinum Toxin Market by Value
3.2.3 Global Cosmetic/Aesthetic Botulinum Toxin Market by Value
3.3 Global Botulinum Toxin Market: Products Analysis
3.3.1 Global Botulinum Toxin Market by Products
3.4 Global Botox Market: An Analysis
3.4.1 Global Botox Market by Value
3.4.2 Global Botox Market by Application
3.5 Global Dysport Market: An Analysis
3.5.1 Global Dysport Market by Value
3.6 Global Xeomin Market: An Analysis
3.6.1 Global Xeomin Market by Value
3.7 Global Botulinum Toxin Market: Regional Analysis
3.7.1 Global Botulinum Toxin Market by Region
4. REGIONAL MARKET ANALYSIS
4.1 The US Botulinum Toxin Market: An Analysis
4.1.1 The US Botulinum Toxin Market by Value
4.1.2 The US Botulinum Toxin Market by Application
4.2 Europe Botulinum Toxin Market: An Analysis
4.2.1 Europe Botulinum Toxin Market by Value
4.2.2 Europe Botulinum Toxin Market by Application
4.3 Japan Botulinum Toxin Market: An Analysis
4.3.1 Japan Botulinum Toxin Market by Value
4.3.2 Japan Botulinum Toxin Market by Application
4.4 Asia (Excluding Japan) Botulinum Toxin Market: An Analysis
4.4.1 Asia (Excluding Japan) Botulinum Toxin Market by Value
4.4.2 Korea Botulinum Toxin Market by Value
4.4.3 China Botulinum Toxin Market by Value
5. MARKET DYNAMICS
5.1 Growth Drivers
5.1.1 Ageing Population
5.1.2 Escalating Number of Plastic Surgeons
5.1.3 Upsurge in Facial Aesthetics Procedures
5.1.4 Rising Alternative of Non-Surgical Procedures
5.1.5 Increasing Healthcare Spending in Emerging Markets
5.2 Challenges
5.2.1 Potential Health Risk Associated with Botulinum Toxin
5.2.2 Botulinum Toxins As Bio-terror Threat
5.3 Market Trends
5.3.1 FDA approval to Botulinum Toxin for new indications
5.3.2 Rise In Medical Tourism
5.3.3 Reduced Safety Concerns and Simple & Instant Characteristic
5.3.4 Scope of Botulinum Toxin in Treatment of Necrotizing Fasciitis
6. COMPETITIVE LANDSCAPE
6.1 Global Botulinum Toxin Market by Players
6.1.1 Global Botulinum Toxin Market Share by Players
6.1.2 Global Botulinum Toxin Market Key Development Schedule for Players
6.2 The US Botulinum Toxin Market Players: An Analysis
6.2.1 The US Botulinum Toxin Market Share by Players
6.3 Europe Botulinum Toxin Market Players: An Analysis
6.3.1 Europe Botulinum Toxin Market Share by Players
7. COMPANY PROFILES
7.1 Allergan Plc.
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategy
7.2 Ipsen
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategy
7.3 Revance Therapeutics, Inc.
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategy
2. INTRODUCTION
2.1 Botulinum Toxin: An Overview
2.2 Botulinum Toxin: Indications Overview
2.3 Botulinum Toxin: Products Overview
3. GLOBAL MARKET ANALYSIS
3.1 Global Botulinum Toxin Market: An Analysis
3.1.1 Global Botulinum Toxin Market by Value
3.2 Global Botulinum Toxin Market: Application Analysis
3.2.1 Global Botulinum Toxin Market by Application
3.2.2 Global Therapeutic Botulinum Toxin Market by Value
3.2.3 Global Cosmetic/Aesthetic Botulinum Toxin Market by Value
3.3 Global Botulinum Toxin Market: Products Analysis
3.3.1 Global Botulinum Toxin Market by Products
3.4 Global Botox Market: An Analysis
3.4.1 Global Botox Market by Value
3.4.2 Global Botox Market by Application
3.5 Global Dysport Market: An Analysis
3.5.1 Global Dysport Market by Value
3.6 Global Xeomin Market: An Analysis
3.6.1 Global Xeomin Market by Value
3.7 Global Botulinum Toxin Market: Regional Analysis
3.7.1 Global Botulinum Toxin Market by Region
4. REGIONAL MARKET ANALYSIS
4.1 The US Botulinum Toxin Market: An Analysis
4.1.1 The US Botulinum Toxin Market by Value
4.1.2 The US Botulinum Toxin Market by Application
4.2 Europe Botulinum Toxin Market: An Analysis
4.2.1 Europe Botulinum Toxin Market by Value
4.2.2 Europe Botulinum Toxin Market by Application
4.3 Japan Botulinum Toxin Market: An Analysis
4.3.1 Japan Botulinum Toxin Market by Value
4.3.2 Japan Botulinum Toxin Market by Application
4.4 Asia (Excluding Japan) Botulinum Toxin Market: An Analysis
4.4.1 Asia (Excluding Japan) Botulinum Toxin Market by Value
4.4.2 Korea Botulinum Toxin Market by Value
4.4.3 China Botulinum Toxin Market by Value
5. MARKET DYNAMICS
5.1 Growth Drivers
5.1.1 Ageing Population
5.1.2 Escalating Number of Plastic Surgeons
5.1.3 Upsurge in Facial Aesthetics Procedures
5.1.4 Rising Alternative of Non-Surgical Procedures
5.1.5 Increasing Healthcare Spending in Emerging Markets
5.2 Challenges
5.2.1 Potential Health Risk Associated with Botulinum Toxin
5.2.2 Botulinum Toxins As Bio-terror Threat
5.3 Market Trends
5.3.1 FDA approval to Botulinum Toxin for new indications
5.3.2 Rise In Medical Tourism
5.3.3 Reduced Safety Concerns and Simple & Instant Characteristic
5.3.4 Scope of Botulinum Toxin in Treatment of Necrotizing Fasciitis
6. COMPETITIVE LANDSCAPE
6.1 Global Botulinum Toxin Market by Players
6.1.1 Global Botulinum Toxin Market Share by Players
6.1.2 Global Botulinum Toxin Market Key Development Schedule for Players
6.2 The US Botulinum Toxin Market Players: An Analysis
6.2.1 The US Botulinum Toxin Market Share by Players
6.3 Europe Botulinum Toxin Market Players: An Analysis
6.3.1 Europe Botulinum Toxin Market Share by Players
7. COMPANY PROFILES
7.1 Allergan Plc.
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategy
7.2 Ipsen
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategy
7.3 Revance Therapeutics, Inc.
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategy
LIST OF FIGURES
Figure 1: Types of Botulinum Toxin
Figure 2: Botulinum Toxin Products
Figure 3: Global Botulinum Toxin Market by Value; 2014-2018 (US$ Billion)
Figure 4: Global Botulinum Toxin Market by Value; 2019-2023 (US$ Billion)
Figure 5: Global Botulinum Toxin Market by Application; 2018 (Percentage,%)
Figure 6: Global Therapeutic Botulinum Toxin Market by Value; 2016-2018 (US$ Billion)
Figure 7: Global Therapeutic Botulinum Toxin Market by Value; 2019-2023 (US$ Billion)
Figure 8: Global Cosmetic/ Aesthetic Botulinum Toxin Market by Value; 2016-2018 (US$ Billion)
Figure 9: Global Cosmetic/ Aesthetic Botulinum Toxin Market by Value; 2019-2023 (US$ Billion)
Figure 10: Global Botulinum Toxin Market by Products; 2018 (Percentage,%)
Figure 11: Global Botox Market by Value; 2016-2018 (US$ Billion)
Figure 12: Global Botox Market by Value; 2019-2023 (US$ Billion)
Figure 13: Global Botox Market by Application; 2018 (Percentage,%)
Figure 14: Global Dysport Market by Value; 2016-2018 (US$ Billion)
Figure 15: Global Dysport Market by Value; 2019-2023 (US$ Billion)
Figure 16: Global Xeomin Market by Value; 2016-2018 (US$ Billion)
Figure 17: Global Xeomin Market by Value; 2019-2023 (US$ Billion)
Figure 18: Global Botulinum Toxin Market by Region;2018 (Percentage,%)
Figure 19: The US Botulinum Toxin Market by Value; 2014-2018 (US$ Billion)
Figure 20: The US Botulinum Toxin Market by Value; 2019-2023 (US$ Billion)
Figure 21: The US Botulinum Toxin Market by Application; 2014-2018 (US$ Billion)
Figure 22: The US Botulinum Toxin Market by Application; 2019-2023 (US$ Billion)
Figure 23: Europe Botulinum Toxin Market by Value; 2014-2018 (US$ Billion)
Figure 24: Europe Botulinum Toxin Market by Value; 2019-2023 (US$ Billion)
Figure 25: Europe Botulinum Toxin Market by Application; 2014-2018 (US$ Billion)
Figure 26: Europe Botulinum Toxin Market by Application; 2019-2023 (US$ Billion)
Figure 27: Japan Botulinum Toxin Market by Value; 2014-2018 (US$ Million)
Figure 28: Japan Botulinum Toxin Market by Value; 2019-2023 (US$ Million)
Figure 29: Japan Botulinum Toxin Market by Application; 2014-2018 (US$ Million)
Figure 30: Japan Botulinum Toxin Market by Application; 2019-2023 (US$ Million)
Figure 31: Asia (Excluding Japan) Botulinum Toxin Market by Value; 2014-2018 (US$ Million)
Figure 32: Asia (Excluding Japan) Botulinum Toxin Market by Value; 2019-2023 (US$ Million)
Figure 33: Korea Botulinum Toxin Market by Value; 2014-2018 (US$ Million)
Figure 34: Korea Botulinum Toxin Market by Value; 2019-2023 (US$ Million)
Figure 35: China Botulinum Toxin Market by Value; 2014-2018 (US$ Million)
Figure 36: China Botulinum Toxin Market by Value; 2019-2023 (US$ Million)
Figure 37: Global Population by Age Groups; 2015-2030 (Million)
Figure 38: Number of Plastic Surgeons by Nations; 2016-2017 (Thousand)
Figure 39: Global Number of Facial Aesthetic Procedures; 2010-2017 (Percentage, %)
Figure 40: Global Healthcare Expenditure; 1995-2022 (US$ Trillion)
Figure 41: Global Botulinum Toxin Market Share by Players; 2018 (Percentage,%)
Figure 42: The US Botulinum Toxin Market Share by Players; 2017 (Percentage,%)
Figure 43: Europe Botulinum Toxin Market Share by Players; 2017 (Percentage,%)
Figure 44: Allergan Plc. Revenue; 2014-2018 (US$ Billion)
Figure 45: Allergan Plc. Revenue by Segments; 2018 (Percentage,%)
Figure 46: Ipsen Net Sales; 2014-2018 (US$ Billion)
Figure 47: Ipsen Net Sales by Segments; 2018 (Percentage,%)
Figure 48: Ipsen Net Sales by Regions; 2018 (Percentage,%)
Figure 49: Revance Therapeutics, Inc. Revenue; 2014-2018 (US$ Thousand)
Figure 50: Revance Therapeutics, Inc. Research and Development Expenditure; 2014-2018 (US$ Million)
Table 1: Applicable Indications of Botulinum Toxin
Table 2: Major Non-surgical Facial Aesthetic Procedures
Table 3: Global Botulinum Toxin Market Key Development Schedule for Players
Figure 1: Types of Botulinum Toxin
Figure 2: Botulinum Toxin Products
Figure 3: Global Botulinum Toxin Market by Value; 2014-2018 (US$ Billion)
Figure 4: Global Botulinum Toxin Market by Value; 2019-2023 (US$ Billion)
Figure 5: Global Botulinum Toxin Market by Application; 2018 (Percentage,%)
Figure 6: Global Therapeutic Botulinum Toxin Market by Value; 2016-2018 (US$ Billion)
Figure 7: Global Therapeutic Botulinum Toxin Market by Value; 2019-2023 (US$ Billion)
Figure 8: Global Cosmetic/ Aesthetic Botulinum Toxin Market by Value; 2016-2018 (US$ Billion)
Figure 9: Global Cosmetic/ Aesthetic Botulinum Toxin Market by Value; 2019-2023 (US$ Billion)
Figure 10: Global Botulinum Toxin Market by Products; 2018 (Percentage,%)
Figure 11: Global Botox Market by Value; 2016-2018 (US$ Billion)
Figure 12: Global Botox Market by Value; 2019-2023 (US$ Billion)
Figure 13: Global Botox Market by Application; 2018 (Percentage,%)
Figure 14: Global Dysport Market by Value; 2016-2018 (US$ Billion)
Figure 15: Global Dysport Market by Value; 2019-2023 (US$ Billion)
Figure 16: Global Xeomin Market by Value; 2016-2018 (US$ Billion)
Figure 17: Global Xeomin Market by Value; 2019-2023 (US$ Billion)
Figure 18: Global Botulinum Toxin Market by Region;2018 (Percentage,%)
Figure 19: The US Botulinum Toxin Market by Value; 2014-2018 (US$ Billion)
Figure 20: The US Botulinum Toxin Market by Value; 2019-2023 (US$ Billion)
Figure 21: The US Botulinum Toxin Market by Application; 2014-2018 (US$ Billion)
Figure 22: The US Botulinum Toxin Market by Application; 2019-2023 (US$ Billion)
Figure 23: Europe Botulinum Toxin Market by Value; 2014-2018 (US$ Billion)
Figure 24: Europe Botulinum Toxin Market by Value; 2019-2023 (US$ Billion)
Figure 25: Europe Botulinum Toxin Market by Application; 2014-2018 (US$ Billion)
Figure 26: Europe Botulinum Toxin Market by Application; 2019-2023 (US$ Billion)
Figure 27: Japan Botulinum Toxin Market by Value; 2014-2018 (US$ Million)
Figure 28: Japan Botulinum Toxin Market by Value; 2019-2023 (US$ Million)
Figure 29: Japan Botulinum Toxin Market by Application; 2014-2018 (US$ Million)
Figure 30: Japan Botulinum Toxin Market by Application; 2019-2023 (US$ Million)
Figure 31: Asia (Excluding Japan) Botulinum Toxin Market by Value; 2014-2018 (US$ Million)
Figure 32: Asia (Excluding Japan) Botulinum Toxin Market by Value; 2019-2023 (US$ Million)
Figure 33: Korea Botulinum Toxin Market by Value; 2014-2018 (US$ Million)
Figure 34: Korea Botulinum Toxin Market by Value; 2019-2023 (US$ Million)
Figure 35: China Botulinum Toxin Market by Value; 2014-2018 (US$ Million)
Figure 36: China Botulinum Toxin Market by Value; 2019-2023 (US$ Million)
Figure 37: Global Population by Age Groups; 2015-2030 (Million)
Figure 38: Number of Plastic Surgeons by Nations; 2016-2017 (Thousand)
Figure 39: Global Number of Facial Aesthetic Procedures; 2010-2017 (Percentage, %)
Figure 40: Global Healthcare Expenditure; 1995-2022 (US$ Trillion)
Figure 41: Global Botulinum Toxin Market Share by Players; 2018 (Percentage,%)
Figure 42: The US Botulinum Toxin Market Share by Players; 2017 (Percentage,%)
Figure 43: Europe Botulinum Toxin Market Share by Players; 2017 (Percentage,%)
Figure 44: Allergan Plc. Revenue; 2014-2018 (US$ Billion)
Figure 45: Allergan Plc. Revenue by Segments; 2018 (Percentage,%)
Figure 46: Ipsen Net Sales; 2014-2018 (US$ Billion)
Figure 47: Ipsen Net Sales by Segments; 2018 (Percentage,%)
Figure 48: Ipsen Net Sales by Regions; 2018 (Percentage,%)
Figure 49: Revance Therapeutics, Inc. Revenue; 2014-2018 (US$ Thousand)
Figure 50: Revance Therapeutics, Inc. Research and Development Expenditure; 2014-2018 (US$ Million)
Table 1: Applicable Indications of Botulinum Toxin
Table 2: Major Non-surgical Facial Aesthetic Procedures
Table 3: Global Botulinum Toxin Market Key Development Schedule for Players
